Semnur Pharmaceuticals (SMNR) Assets (2022 - 2026)
Semnur Pharmaceuticals (SMNR) recorded Assets of $1.94 million in Q2 2026, up 245.4% from $562,462 a year earlier but down 1.3% from the prior quarter.
Powered by 
Analysis
Semnur Pharmaceuticals (SMNR) Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Semnur Pharmaceuticals reported Assets of $1.35 million, down 79.9% from FY2024.
- Annual Assets has declined for three straight years, with a three-year compound annual growth rate of -75.0% (FY2022 to FY2025).
- Across earlier years, Assets came in at $6.68 million in FY2024 (-86.8%), $50.69 million in FY2023 (-41.3%) and $86.28 million in FY2022.
- Quarterly Assets has ranged from $441,882 in Q1 2022 to $90.15 million in Q3 2023 over the past five years.
- On a year-over-year basis, Assets rose in 1 of the last eight quarters, with an average decline of 45.3%.
- Peak year-over-year performance for Assets in the last five years was growth of 245.4% in Q2 2026, against a decline of 98.9% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.97 million (Q1 2026), $1.35 million (Q4 2025) and $774,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Semnur Pharmaceuticals | 85.18 Mn | 84.92 Mn | - | 1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 774,000.00 |
| Jun 30, 2025 | 562,462.00 |
| Mar 31, 2025 | 9.15 Mn |
| Dec 31, 2024 | 6.68 Mn |
| Sep 30, 2024 | 8.92 Mn |
| Jun 30, 2024 | 52.12 Mn |
| Mar 31, 2024 | 51.35 Mn |
| Dec 31, 2023 | 50.69 Mn |
| Sep 30, 2023 | 90.15 Mn |
| Jun 30, 2023 | 88.19 Mn |
| Mar 31, 2023 | 86.96 Mn |
| Dec 31, 2022 | 86.28 Mn |
| Sep 30, 2022 | 85.76 Mn |
| Jun 30, 2022 | 85.53 Mn |
| Mar 31, 2022 | 441,882.00 |
API Access
Semnur Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SMNR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SMNR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SMNR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();